Rockefeller Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Rockefeller Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-280	Closed	-$5K	–	4103
2021 Q3	$5K	Buy	280 +105	+60%	+$2.9K	﹤0.01%	3203
2021 Q2	$6K	Buy	+175	New	+$5.36K	﹤0.01%	3002

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Rockefeller Capital Management's DRNA Position: Q4 2021 in Review

Rockefeller Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 280 shares — an estimated $5K sold.

Rockefeller Capital Management first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $6K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Rockefeller Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Rockefeller Capital Management sold 280 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $5K.
Rockefeller Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Rockefeller Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $6K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Rockefeller Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.